Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXNB2 MET PLXNB1	1.03e-04	12	159	3	GO:0017154
GeneOntologyMolecularFunction	phospholipase binding	KAT5 MET PLA2R1 PTPN11	1.17e-04	32	159	4	GO:0043274
GeneOntologyCellularComponent	uropod	EZR MSN BST1 PIP5K1B	3.61e-06	14	166	4	GO:0001931
GeneOntologyCellularComponent	cell trailing edge	EZR MSN BST1 PIP5K1B	4.89e-06	15	166	4	GO:0031254
GeneOntologyCellularComponent	acrosomal vesicle	TCP11X1 TCP11X2 AKAP3 CD46 DCST2 PRAMEF18 CFAP65 ADAM2 VPS13B	4.10e-05	206	166	9	GO:0001669
GeneOntologyCellularComponent	acrosomal membrane	CD46 DCST2 CFAP65 VPS13B	2.29e-04	38	166	4	GO:0002080
Domain	TIG	PLXNB2 MET NFATC1 NFATC3 CAMTA1 PLXNB1	2.30e-07	31	161	6	PF01833
Domain	IPT	PLXNB2 MET NFATC1 NFATC3 CAMTA1 PLXNB1	2.81e-07	32	161	6	IPR002909
Domain	IPT	PLXNB2 MET NFATC1 NFATC3 PLXNB1	3.10e-06	27	161	5	SM00429
Domain	NPIP	NPIPA1 NPIPA7 NPIPA3 NPIPA2	4.98e-06	14	161	4	IPR009443
Domain	C8	VWF ZAN OTOG	1.31e-04	12	161	3	PF08742
Domain	TIL	VWF ZAN OTOG	1.31e-04	12	161	3	PF01826
Domain	Semap_dom	SEMA3F PLXNB2 MET PLXNB1	1.40e-04	31	161	4	IPR001627
Domain	SEMA	SEMA3F PLXNB2 MET PLXNB1	1.40e-04	31	161	4	PS51004
Domain	Sema	SEMA3F PLXNB2 MET PLXNB1	1.40e-04	31	161	4	SM00630
Domain	Sema	SEMA3F PLXNB2 MET PLXNB1	1.40e-04	31	161	4	PF01403
Domain	Unchr_dom_Cys-rich	VWF ZAN OTOG	1.69e-04	13	161	3	IPR014853
Domain	C8	VWF ZAN OTOG	1.69e-04	13	161	3	SM00832
Domain	TIL_dom	VWF ZAN OTOG	2.13e-04	14	161	3	IPR002919
Domain	Ig_E-set	PLXNB2 MET NFATC1 NFATC3 CAMTA1 PLXNB1	2.83e-04	104	161	6	IPR014756
Domain	VWF_type-D	VWF ZAN OTOG	3.24e-04	16	161	3	IPR001846
Domain	VWFD	VWF ZAN OTOG	3.24e-04	16	161	3	PS51233
Domain	VWD	VWF ZAN OTOG	3.24e-04	16	161	3	SM00216
Domain	VWD	VWF ZAN OTOG	3.24e-04	16	161	3	PF00094
Domain	ERM_C_dom	EZR MSN	4.38e-04	4	161	2	IPR011259
Domain	ERM	EZR MSN	4.38e-04	4	161	2	PF00769
Domain	ERM	EZR MSN	4.38e-04	4	161	2	IPR011174
Domain	VWC_out	VWF ZAN OTOG	5.50e-04	19	161	3	SM00215
Domain	PSI	SEMA3F PLXNB2 MET PLXNB1	5.52e-04	44	161	4	IPR016201
Domain	PSI	SEMA3F PLXNB2 MET PLXNB1	6.55e-04	46	161	4	SM00423
Domain	NFAT	NFATC1 NFATC3	7.26e-04	5	161	2	IPR008366
Domain	FATC	MTOR PRKDC	7.26e-04	5	161	2	PF02260
Domain	FERM_central	EZR MSN TYK2 MYO15A	8.33e-04	49	161	4	IPR019748
Domain	FERM_domain	EZR MSN TYK2 MYO15A	8.33e-04	49	161	4	IPR000299
Domain	FERM_1	EZR MSN TYK2 MYO15A	9.00e-04	50	161	4	PS00660
Domain	FERM_2	EZR MSN TYK2 MYO15A	9.00e-04	50	161	4	PS00661
Domain	FERM_3	EZR MSN TYK2 MYO15A	9.00e-04	50	161	4	PS50057
Domain	Band_41_domain	EZR MSN TYK2 MYO15A	9.00e-04	50	161	4	IPR019749
Domain	B41	EZR MSN TYK2 MYO15A	9.00e-04	50	161	4	SM00295
Domain	EGF_3	RELN ZAN FAT3 CNTNAP5 MALRD1 CNTNAP4 ADAM2 OTOG	1.01e-03	235	161	8	PS50026
Domain	Tudor-knot	KAT5 ARID4A	1.08e-03	6	161	2	PF11717
Domain	Tudor-knot	KAT5 ARID4A	1.08e-03	6	161	2	IPR025995
Domain	FAT	MTOR PRKDC	1.08e-03	6	161	2	PS51189
Domain	FATC	MTOR PRKDC	1.08e-03	6	161	2	PS51190
Domain	FAT	MTOR PRKDC	1.08e-03	6	161	2	PF02259
Domain	PIK-rel_kinase_FAT	MTOR PRKDC	1.08e-03	6	161	2	IPR003151
Domain	FATC_dom	MTOR PRKDC	1.08e-03	6	161	2	IPR003152
Domain	PIK_FAT	MTOR PRKDC	1.08e-03	6	161	2	IPR014009
Domain	FATC	MTOR PRKDC	1.08e-03	6	161	2	SM01343
Domain	HSF_DNA-bind	HSFY1 HSF2	1.51e-03	7	161	2	PF00447
Domain	Moesin_tail	EZR MSN	1.51e-03	7	161	2	IPR008954
Domain	HSF_DOMAIN	HSFY1 HSF2	1.51e-03	7	161	2	PS00434
Domain	HSF_DNA-bd	HSFY1 HSF2	1.51e-03	7	161	2	IPR000232
Domain	HSF	HSFY1 HSF2	1.51e-03	7	161	2	SM00415
Domain	VWA_3	VWA3A VWA5A	2.00e-03	8	161	2	PF13768
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	VWA3A EZR ZC3H14 COG2 ARID4A MTHFD1L SETD4 FRYL PRAMEF18 PLXNB2 IFNLR1 SLC44A5 ARHGEF7 MTOR AMOTL1 TMEM30A CDK5RAP2 SCAF11 EEF1AKMT1 MYO15A USP3 KAT14 RAPGEFL1	5.74e-08	1242	172	23	30973865
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA3F TMEM94 MTHFD1L OBSCN PEX6 FRYL ICE1 DYSF PLXNB2 FBXO46 IFNLR1 TYK2 NCOR2 C2CD3 ARHGEF40 NFATC1 MTOR NPRL3 NLRC5 PRKDC HR	1.49e-07	1105	172	21	35748872
Pubmed	Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.	NPIPA1 NPIPA3 NPIPA2	4.74e-07	4	172	3	18055785
Pubmed	Interplay between scatter factor receptors and B plexins controls invasive growth.	PLXNB2 MET PLXNB1	1.18e-06	5	172	3	15184888
Pubmed	Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections.	SEMA3F RELN PLXNB2 PLXNB1	1.31e-06	17	172	4	11683995
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF20 NBPF19 NBPF15 NBPF10	3.24e-06	21	172	4	16079250
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TMEM94 AKAP3 RNF213 ICE1 RTN1 STRIP2 ALMS1 GUCY1B1 ANAPC1 AMOTL1 TMEM30A DCLRE1A SKA3 USP15 DNMT1	4.09e-06	733	172	15	34672954
Pubmed	S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects.	GRIP1 PPARGC1A NCOR2	4.10e-06	7	172	3	17704298
Pubmed	Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.	EZR CD46 MSN	4.10e-06	7	172	3	12082081
Pubmed	Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney.	WNT11 PLXNB2 MET PLXNB1	4.75e-06	23	172	4	21035938
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MBTPS1 CDS1 ST7 NPEPPS INSR OBSCN RNF213 FRYL SKI UBN2 TYK2 ARFGEF3 EVA1C PHKB NCOR2 NFATC1 NLRC5 SCAF11 CAMTA1 USP15 USP3 VPS13B	4.80e-06	1489	172	22	28611215
Pubmed	MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.	NFATC1 NFATC3 CAMTA1	6.54e-06	8	172	3	23853098
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	EZR RNF181 OBSCN COPG2 FRYL NCSTN PRAMEF18 UBN2 PHKB ZNF750 PPARGC1A CDK5RAP2 CAMTA1 USP3 TNS1 PCDH18 VPS13B PLXNB1	7.92e-06	1084	172	18	11544199
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FRYL ICE1 PHKB ARHGEF40 ANAPC1 MTOR PRKDC DNMT1	8.05e-06	202	172	8	33005030
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN RNF213 IGDCC4 CDK5RAP2 DNAH5 PCDH18	1.15e-05	101	172	6	10997877
Pubmed	Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells.	PLXNB2 MET PLXNB1	1.39e-05	10	172	3	12730235
Pubmed	Exome sequencing in four families with neurodevelopmental disorders: genotype-phenotype correlation and identification of novel disease-causing variants in VPS13B and RELN.	RELN VPS13B	2.43e-05	2	172	2	38771357
Pubmed	High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.	NFATC1 NFATC3	2.43e-05	2	172	2	21514407
Pubmed	Functional regulation of semaphorin receptors by proprotein convertases.	PLXNB2 PLXNB1	2.43e-05	2	172	2	12533544
Pubmed	Brain-derived neurotrophic factor enhances association of protein tyrosine phosphatase PTP1D with the NMDA receptor subunit NR2B in the cortical postsynaptic density.	GRIN2B PTPN11	2.43e-05	2	172	2	10381539
Pubmed	The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.	EZR MTOR	2.43e-05	2	172	2	25952930
Pubmed	Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras.	RALGDS MET	2.43e-05	2	172	2	27773821
Pubmed	Moesin: a member of the protein 4.1-talin-ezrin family of proteins.	EZR MSN	2.43e-05	2	172	2	1924289
Pubmed	Using genomewide mutagenesis screens to identify the genes required for neural tube closure in the mouse.	TBC1D32 C2CD3	2.43e-05	2	172	2	15971254
Pubmed	Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression.	MET PLXNB1	2.43e-05	2	172	2	19940359
Pubmed	Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy.	DYSF PRKDC	2.43e-05	2	172	2	21364666
Pubmed	Positive selection of a gene family during the emergence of humans and African apes.	NPIPA1 NPIPA8	2.43e-05	2	172	2	11586358
Pubmed	MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor.	GRIN2B MET	2.43e-05	2	172	2	36139568
Pubmed	Nonsyndromic Early-Onset Cone-Rod Dystrophy and Limb-Girdle Muscular Dystrophy in a Consanguineous Israeli Family are Caused by Two Independent yet Linked Mutations in ALMS1 and DYSF.	DYSF ALMS1	2.43e-05	2	172	2	26077327
Pubmed	Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.	MET PLXNB1	2.43e-05	2	172	2	20164843
Pubmed	Canalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis.	EZR ABCC2	2.43e-05	2	172	2	26212029
Pubmed	Up-regulated expression of Ezrin and c-Met proteins are related to the metastasis and prognosis of gastric carcinomas.	EZR MET	2.43e-05	2	172	2	21751142
Pubmed	Hemimegalencephaly and intractable seizures associated with the NPRL3 gene variant in a newborn: A case report.	MTOR NPRL3	2.43e-05	2	172	2	33749980
Pubmed	Phosphorylation of 4EBP by oral leucine administration was suppressed in the skeletal muscle of PGC-1α knockout mice.	PPARGC1A MTOR	2.43e-05	2	172	2	26745679
Pubmed	Expression of ezrin and moesin related to invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.	EZR MSN	2.43e-05	2	172	2	25299115
Pubmed	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	MTOR PRKDC	2.43e-05	2	172	2	27235137
Pubmed	Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.	PTPN11 MTOR	2.43e-05	2	172	2	21887223
Pubmed	Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers.	EZR MSN	2.43e-05	2	172	2	12111362
Pubmed	Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice.	PRKDC HR	2.43e-05	2	172	2	21525235
Pubmed	The ERM protein, ezrin, regulates neutrophil transmigration by modulating the apical localization of MRP2 in response to the SipA effector protein during Salmonella Typhimurium infection.	EZR ABCC2	2.43e-05	2	172	2	21899702
Pubmed	Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.	EZR MSN	2.43e-05	2	172	2	28624994
Pubmed	Anti-proliferation and apoptosis induced via the mTOR/PGC-1α signaling pathway in trophoblast cells of miscarriage.	PPARGC1A MTOR	2.43e-05	2	172	2	38395376
Pubmed	DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.	MTOR PRKDC	2.43e-05	2	172	2	32209447
Pubmed	Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma.	EZR MSN	2.43e-05	2	172	2	27042764
Pubmed	Associations between INSR and MTOR polymorphisms in type 2 diabetes mellitus and diabetic nephropathy in a Northeast Chinese Han population.	INSR MTOR	2.43e-05	2	172	2	25867326
Pubmed	Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism.	ZC3H12A MTOR	2.43e-05	2	172	2	30297433
Pubmed	A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism.	INSR MET	2.43e-05	2	172	2	22081023
Pubmed	Specific binding of HIV-1 envelope protein gp120 to the structural membrane proteins ezrin and moesin.	EZR MSN	2.43e-05	2	172	2	9213396
Pubmed	Xenopus Cds1 is regulated by DNA-dependent protein kinase and ATR during the cell cycle checkpoint response to double-stranded DNA ends.	CDS1 PRKDC	2.43e-05	2	172	2	15509799
Pubmed	Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.	EZR MSN	2.43e-05	2	172	2	7579708
Pubmed	Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro.	INSR PTPN11	2.43e-05	2	172	2	8135823
Pubmed	Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.	MET MTOR	2.43e-05	2	172	2	30520540
Pubmed	Ezrin has properties to self-associate at the plasma membrane.	EZR MSN	2.43e-05	2	172	2	7844168
Pubmed	The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.	PTPN11 MTOR	2.43e-05	2	172	2	22058153
Pubmed	mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake.	BST1 MTOR	2.43e-05	2	172	2	22722868
Pubmed	Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.	ZC3H12A MET	2.43e-05	2	172	2	36138026
Pubmed	2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter.	RIPK3 DNMT1	2.43e-05	2	172	2	28564603
Pubmed	Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.	DYSF PRKDC	2.43e-05	2	172	2	22465227
Pubmed	Heterotypic and homotypic associations between ezrin and moesin, two putative membrane-cytoskeletal linking proteins.	EZR MSN	2.43e-05	2	172	2	8248180
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 MTHFD1L DHX37 NPEPPS COPG2 FRYL MSN ANAPC1 MTOR RRP7A SCAF11 PRKDC DNMT1	2.44e-05	653	172	13	22586326
Pubmed	Lessons on conditional gene targeting in mouse adipose tissue.	INSR PPARGC1A PTPN11	2.53e-05	12	172	3	23321074
Pubmed	A balance of noncanonical Semaphorin signaling from the cerebrospinal fluid regulates apical cell dynamics during corticogenesis.	SEMA3F PLXNB2 PLXNB1	2.53e-05	12	172	3	36399562
Pubmed	Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice.	INSR PPARGC1A PTPN11	3.28e-05	13	172	3	23349485
Pubmed	Gene deletion mutants reveal a role for semaphorin receptors of the plexin-B family in mechanisms underlying corticogenesis.	RELN PLXNB2 PLXNB1	6.35e-05	16	172	3	19948886
Pubmed	The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation.	EZR MSN	7.27e-05	3	172	2	8479753
Pubmed	Characterization of lens fiber cell triton insoluble fraction reveals ERM (ezrin, radixin, moesin) proteins as major cytoskeletal-associated proteins.	EZR MSN	7.27e-05	3	172	2	18261459
Pubmed	miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.	MET MTOR	7.27e-05	3	172	2	24810336
Pubmed	Expression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testis.	EZR MSN	7.27e-05	3	172	2	19064715
Pubmed	Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.	EZR MSN	7.27e-05	3	172	2	21864676
Pubmed	Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.	EZR MSN	7.27e-05	3	172	2	14613898
Pubmed	Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin.	EZR MSN	7.27e-05	3	172	2	26555866
Pubmed	Global loss of imprinting leads to widespread tumorigenesis in adult mice.	PRKDC DNMT1	7.27e-05	3	172	2	16226703
Pubmed	Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.	EZR MSN	7.27e-05	3	172	2	16889625
Pubmed	Erythropoietin mediated bone formation is regulated by mTOR signaling.	NFATC1 MTOR	7.27e-05	3	172	2	21898543
Pubmed	Sequential binding of ezrin and moesin to L-selectin regulates monocyte protrusive behaviour during transendothelial migration.	EZR MSN	7.27e-05	3	172	2	29777033
Pubmed	MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.	MET MTOR	7.27e-05	3	172	2	30551391
Pubmed	Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells.	EZR MSN	7.27e-05	3	172	2	21837648
Pubmed	Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines.	NFATC1 NFATC3	7.27e-05	3	172	2	17082579
Pubmed	Activation of Ras requires the ERM-dependent link of actin to the plasma membrane.	EZR MSN	7.27e-05	3	172	2	22132106
Pubmed	Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability.	EZR MSN	7.27e-05	3	172	2	25486435
Pubmed	The AKT-independent MET-V-ATPase-MTOR axis suppresses liver cancer vaccination.	MET MTOR	7.27e-05	3	172	2	32764535
Pubmed	Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM.	EZR MSN	7.27e-05	3	172	2	31843195
Pubmed	NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity.	NFATC1 NFATC3	7.27e-05	3	172	2	7650004
Pubmed	mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.	INSR MTOR	7.27e-05	3	172	2	26584640
Pubmed	Increased phosphorylation of ezrin/radixin/moesin proteins contributes to proliferation of rheumatoid fibroblast-like synoviocytes.	EZR MSN	7.27e-05	3	172	2	21278069
Pubmed	SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway.	PTPN11 MTOR	7.27e-05	3	172	2	17229738
Pubmed	[Study of the correlation of papillary thyroid carcinoma's invasion with Ezrin, Moesin and E-Cadherin].	EZR MSN	7.27e-05	3	172	2	22177047
Pubmed	Physical association of moesin and CD46 as a receptor complex for measles virus.	CD46 MSN	7.27e-05	3	172	2	7884872
Pubmed	MicroRNA‑206 exerts anti‑oncogenic functions in esophageal squamous cell carcinoma by suppressing the c‑Met/AKT/mTOR pathway.	MET MTOR	7.27e-05	3	172	2	30569129
Pubmed	Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones.	PLXNB2 PLXNB1	7.27e-05	3	172	2	15330859
Pubmed	Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women.	ALMS1 MTOR	7.27e-05	3	172	2	29133593
Pubmed	ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.	EZR MSN	7.27e-05	3	172	2	21352885
Pubmed	FTO is required for myogenesis by positively regulating mTOR-PGC-1α pathway-mediated mitochondria biogenesis.	PPARGC1A MTOR	7.27e-05	3	172	2	28333151
Pubmed	Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis.	EZR MSN	7.27e-05	3	172	2	12360288
Pubmed	DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis.	PRKDC DNMT1	7.27e-05	3	172	2	25908435
Pubmed	The cytoplasmic tail of L-selectin interacts with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-dependent binding of Moesin but not Ezrin.	EZR MSN	7.27e-05	3	172	2	11706008
Pubmed	Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer.	MET MTOR	7.27e-05	3	172	2	34830011
Pubmed	The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.	RELN PRKDC	7.27e-05	3	172	2	33615686
Pubmed	The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM.	KAT5 PRKDC	7.27e-05	3	172	2	16603769
Pubmed	Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?	EZR MSN	7.27e-05	3	172	2	25286001
Cytoband	16p13.11	NPIPA1 NPIPA3 NPIPA2	8.81e-05	23	173	3	16p13.11
GeneFamily	Neuroblastoma breakpoint family	NBPF20 NBPF19 NBPF15 NBPF10	7.79e-06	23	102	4	662
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EZR MSN TYK2 MYO15A	1.80e-04	50	102	4	1293
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC3	3.12e-04	5	102	2	665
GeneFamily	Proprotein convertase subtilisin/kexin family	MBTPS1 PCSK9	1.11e-03	9	102	2	973
GeneFamily	Plexins	PLXNB2 PLXNB1	1.11e-03	9	102	2	683
GeneFamily	Olfactory receptors, family 8	OR8J2 OR8J3 OR8J1	2.66e-03	49	102	3	155
Coexpression	PILON_KLF1_TARGETS_UP	MAGEL2 VWF WNT11 INSR GC FRYL FBXO46 C2CD3 AMOTL1 AGMAT TMEM30A NUDCD1 TNKS2 REPS2	4.54e-06	503	167	14	M2226
Coexpression	PILON_KLF1_TARGETS_UP	MAGEL2 VWF WNT11 INSR GC FRYL FBXO46 C2CD3 AMOTL1 AGMAT TMEM30A NUDCD1 TNKS2 REPS2	1.03e-05	541	167	14	MM1061
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL	SEMA3F NPIPA1 CYTL1 SKI NPIPA7 NPIPA8 EVA1C MET GUCY1B1 BST1 NCOA7	1.85e-05	355	167	11	M45758
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F RELN ZAN FAT3 OBSCN GRIN2B ARFGEF3 PPARGC1A CNTNAP4 MYO15A DNAH5 OTOG	8.16e-12	184	172	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F RELN ZAN FAT3 OBSCN GRIN2B ARFGEF3 PPARGC1A CNTNAP4 MYO15A DNAH5 OTOG	8.16e-12	184	172	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F RELN ZAN FAT3 OBSCN GRIN2B ARFGEF3 PPARGC1A CNTNAP4 MYO15A DNAH5 OTOG	8.16e-12	184	172	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CDS1 TMEM116 GC ARFGEF3 P2RX2 PIP5K1B DNAH5	2.44e-06	155	172	7	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDKN3 SETD4 ARFGEF3 PPARGC1A ABCC2 KAT14 PLXNB1	2.66e-06	157	172	7	bd45590da540a557dc8096980a45220fccb99505
ToppCell	LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDKN3 SETD4 ARFGEF3 PPARGC1A ABCC2 KAT14 PLXNB1	2.66e-06	157	172	7	00c9a58b033b8b95b0d838f233dd077b62d8b02a
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	INSR GRIP1 ARFGEF3 MET ZGLP1 SLC44A5 DNAH5	5.86e-06	177	172	7	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM116 RTN1 EVA1C PPARGC1A NEURL1 NCOA7 USP3	6.54e-06	180	172	7	cfc8bfbfd3617aabbb49f9730c29b673ca157e74
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	INSR ARFGEF3 EVA1C MET CNTNAP5 NCOA7 EPHX3	8.10e-06	186	172	7	55fe25f4d0f2bc0fd4802a0a375169f2c41472fc
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	TMEM116 RTN1 EVA1C PPARGC1A NEURL1 NCOA7 PIP5K1B	8.39e-06	187	172	7	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MBTPS1 RNF213 CD46 FRYL TMEM30A PRKDC USPL1	9.63e-06	191	172	7	9454f642c3621370fa23640b631301346b300950
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EZR INSR ARFGEF3 EVA1C MET NCOA7 EPHX3	1.07e-05	194	172	7	855d6acfcf323868ba98b213f06186ad4793d4ed
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EZR INSR ARFGEF3 EVA1C MET NCOA7 EPHX3	1.07e-05	194	172	7	dc531cf9089f2c956621d70d49a2b8219b4b45c1
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EZR INSR ARFGEF3 EVA1C MET NCOA7 EPHX3	1.07e-05	194	172	7	29a7770bdbea6081a9ed64a997cd92a1cbf4af58
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EZR INSR ARFGEF3 EVA1C MET NCOA7 EPHX3	1.07e-05	194	172	7	ca051088f880154ae2fd3f0ab3cef5a8dba8c371
ToppCell	PND01-03-samps-Mesenchymal-Pericyte-pericyte_E\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	MAGEL2 FAT3 OBSCN GUCY1B1 PCDH18 OTOG	1.43e-05	135	172	6	35928195cf34f055b353562c96f451aef2344d64
ToppCell	PND01-03-samps-Mesenchymal-Pericyte\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOK1 MAGEL2 ZAN OBSCN GUCY1B1 PCDH18	2.80e-05	152	172	6	fc9472bc19f997103da535b035105f01429cb08e
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZAN FAT3 GRIN2B CNTNAP5 ADAM2 ABCC2	4.00e-05	162	172	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWA3A ZNF329 CFAP65 CNTNAP5 DNAH5 PLXNB1	5.40e-05	171	172	6	1854a777d9eb9d3fc3ed3632332a6f89ce8131da
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN VWF GRIN2B DCST2 ZNF750 REPS2	5.58e-05	172	172	6	1bad7b19724e1b53ace7e05644215334c9f43910
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3F OBSCN STRIP2 NCOA7 PLXNB1 RAPGEFL1	5.95e-05	174	172	6	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	STRIP2 CFAP65 ARFGEF3 SKA3 REPS2 PCSK9	6.14e-05	175	172	6	fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTYH1 SEMA3F RELN CREB3L4 MET GUCY1B1	6.14e-05	175	172	6	f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DHX37 FAT3 INSR UBN2 FBXO46 ARFGEF3	6.14e-05	175	172	6	dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	STRIP2 CFAP65 ARFGEF3 SKA3 REPS2 PCSK9	6.14e-05	175	172	6	36c140540497bbe1c5f08fac2d94f08cac18fabb
ToppCell	COVID-19-kidney-CD-IC-A\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TMEM116 GRIP1 PPARGC1A CNTNAP5 NEURL1 NCOA7	6.33e-05	176	172	6	45028197364c64e93e3ffe86aff773d47a477d49
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CD46 GRIP1 ARFGEF3 MET SLC44A5 DNAH5	6.33e-05	176	172	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GRIN2B RTN1 ARFGEF3 CNTNAP5 SMIM28 NCOA7	6.95e-05	179	172	6	d96741c5c551e36421b2ad938072ab7d506c3835
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GRIN2B RTN1 ARFGEF3 CNTNAP5 SMIM28 NCOA7	6.95e-05	179	172	6	b8ca29aebd25ebac441bebd769bbf98c536d3166
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	EZR GRIP1 ARFGEF3 MET NCOA7 DNAH5	7.39e-05	181	172	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	IIH-Treg-proli_CD4\|IIH / Condition, Cell_class and T cell subcluster	PEX6 NBPF20 ALMS1 MTOR NCOA7 MYO15A	7.62e-05	182	172	6	5c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EZR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	7.62e-05	182	172	6	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF DYSF EVA1C PTPN11 CAMTA1 USP15	8.10e-05	184	172	6	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A TMEM107 CFAP65 EVA1C TBC1D32 DNAH5	8.10e-05	184	172	6	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A TMEM107 CFAP65 EVA1C TBC1D32 DNAH5	8.10e-05	184	172	6	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A TMEM107 CFAP65 EVA1C TBC1D32 DNAH5	8.10e-05	184	172	6	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	LPS_only\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZC3H12A MTHFD1L RNF213 EVA1C USP15 VPS13B	8.34e-05	185	172	6	a72ccb147ca505880e2da8f6a70b9d570464a691
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM116 IFNLR1 ARFGEF3 EVA1C PPARGC1A PLXNB1	8.59e-05	186	172	6	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM116 IFNLR1 ARFGEF3 EVA1C PPARGC1A PLXNB1	8.59e-05	186	172	6	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	EZR INSR GRIP1 ARFGEF3 MET SLC44A5	8.85e-05	187	172	6	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDS1 TMEM116 ARFGEF3 MET PIP5K1B PLXNB1	9.11e-05	188	172	6	b1049003ca79c340bb8c78da66bdc0956e1aebc2
ToppCell	facs-Lung-EPCAM-3m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDS1 TMEM116 ARFGEF3 MET PIP5K1B PLXNB1	9.11e-05	188	172	6	3dd571bd8e7358b4346dea71f6bf9602dabf583c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EZR KLF6 RNF213 IGDCC4 MET DNAH5	9.38e-05	189	172	6	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	INSR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	9.38e-05	189	172	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EZR KLF6 RNF213 IGDCC4 MET DNAH5	9.38e-05	189	172	6	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	INSR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	9.66e-05	190	172	6	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EZR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	9.94e-05	191	172	6	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF INSR DYSF ARHGEF7 NCOA7 TNS1	9.94e-05	191	172	6	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CDS1 GRIN2B ARFGEF3 CNTNAP5 CNTNAP4 CAMTA1	9.94e-05	191	172	6	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CDS1 GRIN2B ARFGEF3 CNTNAP5 CNTNAP4 CAMTA1	9.94e-05	191	172	6	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	Ciliated-cil-3\|World / Class top	VWA3A CDS1 WNT11 TMEM107 CFAP65 DNAH5	1.02e-04	192	172	6	4989ebb8812b8af1870599acd932849122c05a29
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA3F INSR STRIP2 MSN TMEM30A SCAF11	1.02e-04	192	172	6	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	VWA3A TMEM116 STRIP2 AGMAT PCSK9	1.03e-04	120	172	5	a6d0406a174d46ce06b41280292931954af88a59
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	FRYL ARFGEF3 SCAF11 PRKDC SMCR8 VPS13B	1.05e-04	193	172	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	EZR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	1.05e-04	193	172	6	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	facs-Lung-3m-Epithelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CDS1 TMEM116 ARFGEF3 MET PIP5K1B PLXNB1	1.05e-04	193	172	6	db5e43e0b571737e7006365bdf0575340b8b900b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EZR KLF6 RNF213 MET SLC44A5 DNAH5	1.08e-04	194	172	6	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN MAGEL2 STRIP2 GRIP1 SLC44A5	1.11e-04	122	172	5	1720756e0b3e8db14a9ccabe83f9b41689a4f754
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EZR INSR MET HOXB1 NCOA7 EPHX3	1.11e-04	195	172	6	6095bb237d7bc75cbaeaeb492f6948f3c3fa4848
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	CACNA1F CDS1 PLXNB2 ARFGEF3 MET PLXNB1	1.18e-04	197	172	6	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	VWA3A CDS1 CFAP65 ARFGEF3 MET DNAH5	1.18e-04	197	172	6	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	INSR GRIP1 ARFGEF3 MET SLC44A5 DNAH5	1.21e-04	198	172	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRIP1 ARFGEF3 MET SLC44A5 REPS2 DNAH5	1.21e-04	198	172	6	5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRIP1 ARFGEF3 MET SLC44A5 REPS2 DNAH5	1.21e-04	198	172	6	6ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-dn_T\|Leuk-UTI / Disease, condition lineage and cell class	KAT5 IFNLR1 ANAPC1 AGMAT DCLRE1A TNKS2	1.24e-04	199	172	6	aa4d8ce8994e5032a33d5cc68c482882147cdc3b
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	EZR KLF6 INSR CD46 PTPN11 NCOA7	1.24e-04	199	172	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	Sigmoid-T_cell-Tcm\|T_cell / Region, Cell class and subclass	CTSF COPG2 PLAC8L1 MTOR ZBTB5 NLRC5	1.24e-04	199	172	6	acdf95f4d58df47690f4ae254245bc618f9ac07e
ToppCell	(06)_OLFM4+\|World / shred by cell type by condition	EZR INSR CD46 PPARGC1A VWA5A NCOA7	1.24e-04	199	172	6	c773b9180dbfec9c19d4098dd43332e6f6050372
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTYH1 RTN1 GRIP1 ARFGEF3 PLA2R1 PIP5K1B	1.28e-04	200	172	6	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TTYH1 CNMD STRIP2 IGDCC4 EVA1C PLA2R1	1.28e-04	200	172	6	b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN MAGEL2 GRIP1 PIP5K1B PCDH18	1.34e-04	127	172	5	f808c727c0817ed10e76eaffa9493a516e9a6b50
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DYSF STRIP2 EVA1C SLC44A5 TNS1	1.67e-04	133	172	5	840e8240db29cd21ed9830843c0fa6d65b8f300a
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	ZC3H14 CNTNAP5 CNTNAP4	8.59e-06	8	160	3	DOID:0060308 (implicated_via_orthology)
Disease	OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO	TBC1D32 MET	2.92e-05	2	160	2	C4085248
Disease	Osteofibrous Dysplasia	TBC1D32 MET	2.92e-05	2	160	2	C1709353
Disease	Beta blocking agent use measurement	INSR MET PTPN11 GUCY1B1 NPRL3 PCDH18	3.81e-05	114	160	6	EFO_0009929
Disease	developmental disorder of mental health (implicated_via_orthology)	GRIN2B PLXNB2 NCOR2 PLXNB1	1.46e-04	49	160	4	DOID:0060037 (implicated_via_orthology)
Disease	triglycerides to total lipids in small VLDL percentage	KAT5 NPIPA1 NPIPA2 PCSK9	2.81e-04	58	160	4	EFO_0022338
Disease	cardiovascular disease biomarker measurement, ankle brachial index	FAT3 DNAH5	2.89e-04	5	160	2	EFO_0003912, EFO_0005278
Disease	immunoglobulin superfamily DCC subclass member 4 measurement	DPP8 IGDCC4	2.89e-04	5	160	2	EFO_0801690
Disease	ICAM-1 measurement	TYK2 ZGLP1 DNMT1	2.91e-04	24	160	3	EFO_0004520
Disease	migraine disorder, type 2 diabetes mellitus	FRYL SKI CREB3L4 NCOA7	3.21e-04	60	160	4	MONDO_0005148, MONDO_0005277
Disease	amino acid measurement	MOXD2P VWF OR5T2 GRIN2B TMEM107 TYK2 GHRHR PLA2R1 ALMS1 PRKDC CAMTA1 TNKS2	3.45e-04	678	160	12	EFO_0005134
Disease	age related macular degeneration (implicated_via_orthology)	CD46 PPARGC1A	4.32e-04	6	160	2	DOID:10871 (implicated_via_orthology)
Disease	Orofaciodigital Syndromes	TMEM107 C2CD3	4.32e-04	6	160	2	C0029294
Disease	serum metabolite measurement	MAGEL2 GC TBC1D13 PHKB ALMS1 SLC44A5 NFATC1 NPRL3 AGMAT NCOA7 ABCC2 PCSK9 DNMT1 PHLPP2	6.63e-04	945	160	14	EFO_0005653
Disease	renal cell carcinoma (is_marker_for)	VWF WNT11 INSR CD46 MTOR	6.81e-04	128	160	5	DOID:4450 (is_marker_for)
Disease	fatty liver disease (biomarker_via_orthology)	INSR PPARGC1A ABCC2	7.58e-04	33	160	3	DOID:9452 (biomarker_via_orthology)
Disease	placental insufficiency (biomarker_via_orthology)	GRIN2B PPARGC1A	8.01e-04	8	160	2	DOID:3891 (biomarker_via_orthology)
Disease	Lung diseases	INSR BST1 PRKDC DNAH5	8.69e-04	78	160	4	C0024115
Disease	Nonsyndromic Deafness	MET P2RX2 MYO15A OTOG	1.00e-03	81	160	4	C3711374
Disease	sexual dimorphism measurement	SEMA3F RIPK3 KAT5 NPEPPS INSR FRYL DYSF TRIM27 NCOR2 ARHGEF40 NPRL3 EFR3B NLRC5 NPAS4 RAPGEFL1	1.04e-03	1106	160	15	EFO_0021796
Disease	obesity (implicated_via_orthology)	KAT5 PLXNB2 TYK2 PPARGC1A ALMS1 PLXNB1	1.17e-03	215	160	6	DOID:9970 (implicated_via_orthology)
Disease	thalamus volume	SEMA3F FAT3 PPARGC1A CAMTA1	1.20e-03	85	160	4	EFO_0006935
Disease	Myopia	CDKN3 ST7 GRIN2B DYSF RTN1 CNTNAP5 CNTNAP4 VPS13B	1.25e-03	385	160	8	HP_0000545
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	INSR PPARGC1A MTOR ABCC2 DNMT1	1.27e-03	147	160	5	DOID:9352 (biomarker_via_orthology)
Disease	valine measurement	MALRD1 NFATC1 USP15	1.33e-03	40	160	3	EFO_0009792
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	KAT5 TMEM116 INSR PTPN11 NLRC5 PCSK9	1.37e-03	222	160	6	EFO_0008317, EFO_0020943
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	NPIPA1 GC NCOR2 NLRC5 NPIPA2 PCSK9	1.44e-03	224	160	6	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	NPIPA1 GC NCOR2 NLRC5 NPIPA2 PCSK9	1.47e-03	225	160	6	EFO_0008317, EFO_0010351
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	KAT5 TMEM116 NPEPPS PTPN11 NLRC5 PCSK9	1.47e-03	225	160	6	EFO_0008317, EFO_0020947
Disease	hypertension	INSR RNF213 PLXNB2 NCOR2 GUCY1B1 NPRL3 PCDH18	1.48e-03	307	160	7	EFO_0000537
Disease	PR interval	ARID4A WNT11 OBSCN SKI DYSF PPARGC1A ARHGEF40 NUDCD1 CAMTA1	1.58e-03	495	160	9	EFO_0004462
Disease	Colorectal Carcinoma	RALGDS MTHFD1L OBSCN AKAP3 SETD4 CD46 GHRHR NFATC1 NEURL1 ABCC2 HR	1.62e-03	702	160	11	C0009402
Disease	schizophrenia (is_marker_for)	RELN VWF DNMT1	1.76e-03	44	160	3	DOID:5419 (is_marker_for)
Disease	ovarian reserve	GRIN2B NPRL3	1.86e-03	12	160	2	EFO_0004770
Disease	left atrial volume measurement	FBXO46 NPRL3	1.86e-03	12	160	2	EFO_0600035
Disease	cholesterol to total lipids in large VLDL percentage	TMEM116 NLRC5 PCSK9	1.88e-03	45	160	3	EFO_0022236
Disease	intraocular pressure measurement	SEMA3F RELN ST7 PCDHGA5 EVA1C ANAPC1 MTOR NEURL1 TNS1	1.91e-03	509	160	9	EFO_0004695
Disease	Fulminant Hepatic Failure with Cerebral Edema	GC PRKDC	2.19e-03	13	160	2	C0751197
Disease	Hepatic Stupor	GC PRKDC	2.19e-03	13	160	2	C0751198
Disease	phosphatidylcholine 40:7 measurement	NPIPA1 NPIPA2	2.19e-03	13	160	2	EFO_0021477
Disease	Hepatic Encephalopathy	GC PRKDC	2.19e-03	13	160	2	C0019151
Disease	Hepatic Coma	GC PRKDC	2.19e-03	13	160	2	C0019147
Disease	Malignant neoplasm of breast	CDS1 VWF OBSCN FAM131A DYSF OR1N1 PHKB MTOR NLRC5 REPS2 TNS1 VPS13B PLXNB1 DNMT1	2.21e-03	1074	160	14	C0006142
Disease	cholesteryl esters to total lipids in small VLDL percentage	TMEM116 NLRC5 PCSK9	2.40e-03	49	160	3	EFO_0022256
Disease	triglycerides to total lipids in medium LDL percentage	NPIPA1 NPIPA2 PCSK9	2.54e-03	50	160	3	EFO_0022334
Disease	triglycerides to total lipids in large LDL percentage	NPIPA1 NPIPA2 PCSK9	2.69e-03	51	160	3	EFO_0022331
Disease	Alzheimer's disease (is_marker_for)	RELN INSR GRIN2B PPARGC1A GUCY1B1 ADAM2	2.86e-03	257	160	6	DOID:10652 (is_marker_for)
Disease	serum alanine aminotransferase measurement	EZR INSR PEX6 CYTL1 SKI PLXNB2 MET PTPN11 CCDC97 ABCC2 USP3 DNMT1	2.86e-03	869	160	12	EFO_0004735
Disease	hepatocellular carcinoma (biomarker_via_orthology)	INSR GC MET DNMT1	2.88e-03	108	160	4	DOID:684 (biomarker_via_orthology)
Disease	Alopecia, Male Pattern	ABCC2 HR	2.93e-03	15	160	2	C4083212
Disease	Androgenetic Alopecia	ABCC2 HR	2.93e-03	15	160	2	C0162311
Disease	Female pattern alopecia (disorder)	ABCC2 HR	2.93e-03	15	160	2	C0263477
Disease	alcohol consumption measurement	SEMA3F RELN ARID4A GRIN2B GRIP1 NCOR2 CNTNAP5 ALMS1 MTOR CDK5RAP2 SCAF11 CAMTA1 MYO15A DNAH5 PHLPP2	3.20e-03	1242	160	15	EFO_0007878
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 PTPN11	3.34e-03	16	160	2	DOID:0060250 (implicated_via_orthology)
Disease	diabetic retinopathy (implicated_via_orthology)	INSR PPARGC1A	3.34e-03	16	160	2	DOID:8947 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in large VLDL percentage	KAT5 TMEM116 PCSK9	3.51e-03	56	160	3	EFO_0022250
Disease	metabolite measurement	INSR ICE1 TBC1D13 ALMS1 SLC44A5 BST1 AGMAT ABCC2 PCSK9	3.61e-03	560	160	9	EFO_0004725
Disease	neurofilament light chain measurement	CNTNAP5 MYO15A SMCR8	3.69e-03	57	160	3	EFO_0009178
Disease	Carcinoma, Granular Cell	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0205644
Disease	Adenocarcinoma, Tubular	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0205642
Disease	Carcinoma, Cribriform	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0205643
Disease	Adenocarcinoma, Basal Cell	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0205641
Disease	Adenocarcinoma	MET PTPN11 MTOR DNMT1	3.72e-03	116	160	4	C0001418
Disease	neuroblastoma	LINC01559 EVA1C ARHGEF40 DNAH5	3.72e-03	116	160	4	EFO_0000621
Disease	Benign neoplasm of stomach	KLF6 MET	3.77e-03	17	160	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	KLF6 MET	3.77e-03	17	160	2	C0496905
Disease	Carcinoma in situ of stomach	KLF6 MET	3.77e-03	17	160	2	C0154060
Disease	diastolic blood pressure, alcohol drinking	KAT5 INSR GUCY1B1 NPRL3	3.96e-03	118	160	4	EFO_0004329, EFO_0006336
Disease	non-alcoholic fatty liver disease (is_implicated_in)	PPARGC1A ABCC2	4.22e-03	18	160	2	DOID:0080208 (is_implicated_in)
Disease	phosphatidylcholine measurement	LINC01559 NPIPA1 PEX6 NCOR2 MALRD1 NPIPA2	4.65e-03	284	160	6	EFO_0010226
Disease	reticulocyte count	SEMA3F CDKN3 VWF KAT5 INSR SKI PLXNB2 PTPN11 NPRL3 NCOA7 USP3 TNS1 DNMT1	4.67e-03	1045	160	13	EFO_0007986
Disease	Congenital hernia of foramen of Morgagni	WNT11 INSR	4.70e-03	19	160	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	WNT11 INSR	4.70e-03	19	160	2	C0265700
Disease	bipolar disorder (is_marker_for)	RELN VWF	4.70e-03	19	160	2	DOID:3312 (is_marker_for)
Disease	Pseudopelade	ABCC2 HR	4.70e-03	19	160	2	C0086873
Disease	Alopecia	ABCC2 HR	4.70e-03	19	160	2	C0002170
Disease	leukemia (implicated_via_orthology)	PTPN11 MEIS3P2	4.70e-03	19	160	2	DOID:1240 (implicated_via_orthology)
Disease	temporal lobe epilepsy (is_marker_for)	RELN GRIN2B	5.21e-03	20	160	2	DOID:3328 (is_marker_for)
Disease	end stage renal disease (implicated_via_orthology)	MTOR ABCC2	5.21e-03	20	160	2	DOID:783 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	KAT5 NPEPPS NPIPA1 NLRC5 NPIPA2 PCSK9	5.23e-03	291	160	6	EFO_0008317, EFO_0020946
Disease	systolic blood pressure, alcohol drinking	KAT5 INSR GUCY1B1 NPRL3	5.28e-03	128	160	4	EFO_0004329, EFO_0006335

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSDFCSNPDPYVLNL	TTYH1	271	Q9H313
VALDKDPCSVLPSDY	BST1	76	Q10588
DPCSVLPSDYDLFIN	BST1	81	Q10588
STYCVLNTVPPIEDD	CAMTA1	26	Q9Y6Y1
VEDCVQSTLAALYPP	ARHGEF40	6	Q8TER5
YPALVISPSCNDDIT	ARID4A	191	P29374
CEPSELFQLQTYSLP	CDS1	321	Q92903
DCVSVIPDDSSKPLY	DNMT1	761	P26358
YEALQTLCSAPPSDV	TBC1D32	191	Q96NH3
SASYLPPDCSVQSDL	ADAM2	636	Q99965
QDYVAPDLPSCIFLE	ALMS1	2911	Q8TCU4
GNSYDCDDPLVSALP	CNTNAP4	26	Q9C0A0
ACYSPSSPVQVLEDS	AMOTL1	21	Q8IY63
VYPEPRSESECLSNI	ARHGEF7	56	Q14155
LPTRPCFYDIDLDTE	MTHFD1L	956	Q6UB35
SYEIDSEICPPDDLA	CDK5RAP2	1046	Q96SN8
ASCSYPDLQPGEVLE	IGDCC4	1206	Q8TDY8
PQPNYADTLLSEESC	PCDHGA5	771	Q9Y5G8
SINPEIVCDPLSDYN	NCSTN	241	Q92542
SLEPLPCYQLELDAA	NUDCD1	26	Q96RS6
ECLLYPLPPSADDNL	NPIPA1	291	Q9UND3
LPPSLDTYSECSEVD	PCDH18	1016	Q9HCL0
PVDVDTNTPCYALLE	ANAPC1	1621	Q9H1A4
LSYLDEQAGTPPCSV	CACNA1F	1756	O60840
DEEPKPLLCSQYETL	NCOR2	2496	Q9Y618
LLESPSYTVCVSEPD	HSFY1	56	Q96LI6
SLPYALQDPFACVEA	MAGEL2	816	Q9UJ55
LLLYSFSDACEEPPT	CD46	26	P15529
LKYAESDPTVPCNET	MBTPS1	136	Q14703
QASLSPSYIDLTECP	MBTPS1	481	Q14703
EEILSANATYQLPPC	IFNLR1	136	Q8IU57
ESNKELPVLCPDYLS	KRT39	131	Q6A163
TLRPSLSYPLAACDQ	MYO15A	1056	Q9UKN7
TDSLDPEKLLQCPYD	GTSF1	6	Q8WW33
LNSYLERDPTPCELT	CFAP65	1136	Q6ZU64
STEDYNVACILTLPP	KAT5	361	Q92993
PACPLSNLLLQSYEE	CCDC97	216	Q96F63
ENLAASLPLPEYCAL	HR	951	O43593
DACLYSPASAPEVIT	PCSK9	321	Q8NBP7
QLPVDTLDAYPCGSD	PLXNB1	366	O43157
TLTETDLYCEPPEVQ	PLXNB2	1141	O15031
CDLYQLISPSRDALP	FBXO46	306	Q6PJ61
SSVYCDDIDLEDIPP	OPTC	136	Q9UBM4
PPQLTGADLYSLCSD	PEX6	906	Q13608
LYSICSEPLIELSNP	PIP5K1B	106	O14986
SDRLCLPYIPQLTDE	EFR3B	671	Q9Y2G0
PGIDLSECLQYPDFS	KAT14	661	Q9H8E8
LLYCPSSIDLQTLAE	FRYL	756	O94915
LSPNASVCLYSPLAE	NPRL3	336	Q12980
EEEDLKCLPRYPSLS	PRAMEF18	306	Q5VWM3
TLSLPSLEAYRDPSC	NFATC1	156	O95644
SLEAYRDPSCLSPAS	NFATC1	161	O95644
DPPYLSEECLRKTSE	EEF1AKMT1	141	Q8WVE0
LNDDIYCPPETAVLL	MSN	111	P26038
LDSPEADLPLCFEQT	ABCC2	16	Q92887
IYLPEADSILFLCSP	GUCY1B1	311	Q02153
NPEYLSASDVFPCSV	INSR	996	P06213
IELKYPLNCADPTSE	PTPN11	96	Q06124
ECLLYPLPPSADDNL	NPIPA3	291	F8WFD2
DDCNALEYPIPVTTV	CYTL1	116	Q9NRR1
ADDNLKTPAECLLYP	NPIPA2	301	E9PIF3
IAPLLALSCSDTYIP	OR8J3	181	Q8NGG0
ESALYLLETLPSCPR	NLRC5	1286	Q86WI3
LNSVLDPVLYCFSSP	OXER1	346	Q8TDS5
YCDDPETSLPTQLKD	RELN	2506	P78509
REDFEDYPASCLSLP	MEIS3P2	166	A8K0S8
PDPGLLSYINELCSQ	NUTM1	406	Q86Y26
PELLPCLAERASYSE	OBSCN	7751	Q5VST9
PCSELLKYLTTNDDP	PPARGC1A	206	Q9UBK2
DVPLLALSCSDTYIP	OR8J2	181	Q8NGG1
DLDLPASECNPKYSF	P2RX2	271	Q9UBL9
VDDISFQDCSPLLSP	MALRD1	1246	Q5VYJ5
SYEDQLTPCTSTFPD	NPAS4	496	Q8IUM7
NVPLLALSCSDTYLP	OR8J1	181	Q8NGP2
ERLPPFDCLSYSALQ	EVA1C	206	P58658
YADLLSEDKETPCPS	HOXB1	156	P14653
AVYALCDLSPSNPAE	ICE1	2216	Q9Y2F5
SPGSDVYCISELNDP	C2CD3	426	Q4AC94
DSLRIAPCPSQDSLY	DOK1	301	Q99704
APCPSQDSLYSDPLD	DOK1	306	Q99704
GAPSTDLCLPALDYL	ARFGEF3	1381	Q5TH69
CVSLYKLSSPEDDPT	DPP8	596	Q6V1X1
SPVCDQVAYTALLPE	FAT3	3026	Q8TDW7
SLYSLEATLEEPPCN	CTSF	76	Q9UBX1
YNSPLTESCLSPAEE	FAM131A	306	Q6UXB0
SDSYEVLSCIPAPSL	COPG2	681	Q9UBF2
DSSALLNPSKECEPY	TMEM30A	146	Q9NV96
ACPVPLELLAEEESY	GHRHR	111	Q02643
PSDAPRDVDCYTIDL	EPHX3	136	Q9H6B9
TESYNLSCELEPPSE	RALGDS	636	Q12967
RSFYLQLCPPSDASE	GARIN6	146	Q8NEG0
QLLLDDDCPTAIFPS	SLC44A5	161	Q8NCS7
LSDEIYCPPETAVLL	EZR	111	P15311
LPLPENDFSDCEISY	DCLRE1A	286	Q6PJP8
CASPLSYQGDLDLEL	DCST2	641	Q5T1A1
LTDVLEDAPAESPYC	COG2	401	Q14746
PLISYIEADSPAERC	GRIP1	501	Q9Y3R0
AACLLLYLSDTISPE	CDKN3	151	Q16667
ALLPSYCQFDKPLEE	DHX37	1006	Q8IY37
YQPVSCPLSDLSENV	SCAF11	561	Q99590
SVSDQDNYIPCTLEP	DYSF	1611	O75923
ADVSPINYSLCLKPD	NPEPPS	56	P55786
LFIDPNEVYCSEASP	CREB3L4	71	Q8TEY5
TNYNCDDPLASLLSP	CNTNAP5	26	Q8WYK1
LEKCCDPLYSSDPLS	DNAH5	351	Q8TE73
LLPCISYPAFALDDE	PHKB	296	Q93100
LFYLCELAPAPLDSD	HSF2	516	Q03933
PPDTYLDTQADLCVP	OTOG	826	Q6ZRI0
LIPEDDTTYACTFLP	MOXD2P	201	A6NHM9
AYLCPPSIASEEKDI	OR1N1	256	Q8NGS0
LACADPVPSSLYSLI	OR52I1	191	Q8NGK6
DPDPDIRYCVLASLD	MTOR	666	P42345
ADDNLKTPAECLLYP	NPIPA7	301	E9PJI5
ADDNLKTPAECLLYP	NPIPA8	301	P0DM63
CVAPYPSLLSSEDNA	MET	1361	P08581
TSLISDICYPPQEDS	RTN1	106	Q16799
DPDTAYPSLILSDNL	TRIM27	321	P14373
CPYDPKLDTASALIN	SEMA3F	201	Q13275
DYPCCTIQDLPELTT	STRIP2	631	Q9ULQ0
NSCPLCRYELPTDDD	RNF181	111	Q9P0P0
EQLLSTPPDFTCALE	TCP11X1	96	B4DZS4
EQLLSTPPDFTCALE	TCP11X2	11	Q5H9J9
DALPSDLPQDLCPLY	NCOA7	291	Q8NI08
PEVLQDSLDRCYSTP	NBPF10	1361	Q6P3W6
PEVLQDSLDRCYSTP	NBPF10	1436	Q6P3W6
PEVLQDSLDRCYSTP	NBPF10	1511	Q6P3W6
PEVLQDSLDRCYSTP	NBPF10	2581	Q6P3W6
PEVLQDSLDRCYSTP	NBPF10	2656	Q6P3W6
PEVLQDSLDRCYSTP	NBPF10	2731	Q6P3W6
PEVLQDSLDRCYSTP	NBPF15	601	Q8N660
PEVLQDSLDRCYSTP	NBPF19	846	A0A087WUL8
PEVLQDSLDRCYSIP	NBPF19	921	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	996	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	2066	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	2141	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	2216	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	3286	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF19	3436	A0A087WUL8
EVLQDPLDRCYSTPS	NBPF19	3606	A0A087WUL8
PEVLQDSLDRCYSTP	NBPF20	746	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	821	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	896	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	1966	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	2041	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	2116	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	3261	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	3336	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	4406	P0DPF2
PEVLQDSLDRCYSTP	NBPF20	4481	P0DPF2
CPEDLSLLNIYSPLL	PLAC8L1	11	A1L4L8
AEPDTCALAPYLDLL	SETD4	221	Q9NVD3
EATLPSQCLPPSYEE	SMIM28	121	A0A1B0GU29
CDLVEVSPPYDLSGN	AGMAT	316	Q9BSE5
YPICTETADRELLPS	ST7	486	Q9NRC1
VFCDIPPLLAISYSD	OR5T2	216	Q8NGG2
APEQPLSLYECDSTL	PLA2R1	96	Q13018
LLVPELYSSPSAACI	SKI	231	P12755
NPDESADTDLYTCRP	SMCR8	286	Q8TEV9
LTSAFPDSLYECLPA	AKAP3	706	O75969
PDEDTSCSTIYLPLK	LINC01559	26	Q495D7
DDVEFCSPPAYATLT	CNMD	16	O75829
VPPYCTEESLSRLLS	RRP7A	66	Q9Y3A4
SDAEYTNSPLVPTFC	SKA3	276	Q8IX90
LPTYDEVLLCTPATT	RNF213	1856	Q63HN8
PECDAPLLSVYGTQD	ZNF750	266	Q32MQ0
DCESIEDLLNELPYP	USPL1	931	Q5W0Q7
ELPYPIDIASESACT	USPL1	941	Q5W0Q7
SDCRLESEAPYLLSP	ZBTB5	436	O15062
PTDESCVEFSYPELL	UBN2	136	Q6ZU65
LPQTLDSLPYVSQDC	ZC3H12A	421	Q5D1E8
DEIVSYLCDLAPEAP	VWF	1451	P04275
DSLPKYACPDLVSQS	NEURL1	136	O76050
LLCYIRPDTADPASS	PHLPP2	876	Q6ZVD8
PPLLLSEGEQQCYSE	REPS2	26	Q8NFH8
ELPTEPSLVYEAVCN	RIPK3	221	Q9Y572
DISIALDPLYPSRCS	TMEM94	1016	Q12767
YPLNTVTFCDLDPQE	TNS1	1661	Q9HBL0
CLPLTFTPEEYDKQD	TMEM107	36	Q6UX40
ELPPSANTSVCSTLY	TMEM116	71	Q8NCL8
NSPPLYCDSEIDAEL	GC	456	P02774
CLSNTPPLTEYFLND	USP15	306	Q9Y4E8
SRPADLEPDDCASIY	NFATC3	31	Q12968
TDYPCLLILDPQNEF	TBC1D13	141	Q9NVG8
QSNCPLSPTEYLGED	VWA5A	196	O00534
EVCSLLLSYGADPTL	TNKS2	291	Q9H2K2
LEYCSTASIDSENPP	PRKDC	3011	P78527
LLEPENSGPESCLYD	USP3	441	Q9Y6I4
CSSIELAPNYLLDLE	WNT11	91	O96014
EYDPSDCAVPISTSL	VPS13B	2901	Q7Z7G8
CLDAISSLLYLPPEQ	PSMD5	361	Q16401
CTRDSYEALVPLPEE	RAPGEFL1	396	Q9UHV5
CEPEVLNSLEETYSP	ZC3H14	261	Q6PJT7
DSSLQIIPTYSLPCS	ZGLP1	156	P0C6A0
SNVSGLDCDPALPSY	ZNF329	96	Q86UD4
SCPDQPSEILSDYIQ	VWA3A	271	A6NCI4
DPQDRESLSCSYPVS	ZNF311	126	Q5JNZ3
LYELLTHCDSSQSPP	TYK2	1091	P29597
SELYDTLPSILCQPG	ZAN	2606	Q9Y493
PEDTLISPSFCYNLE	KLF6	86	Q99612
SASSIDGLYDCDNPP	GRIN2B	996	Q13224